Article Details

Update on biosimilars in Canada – June 2022 | Smart & Biggar - JDSupra

Retrieved on: 2022-06-30 19:56:54

Tags for this article:

Click the tags to see associated articles and topics

Update on biosimilars in Canada – June 2022 | Smart & Biggar - JDSupra. View article details on hiswai:

Excerpt

Samsung Bioepis's ONTRUZANT, biosimilar of Hoffmann La Roche's HERCEPTIN (trastuzumab). This brings the total biosimilars approved to 47 biosimilars ...

Article found on: www.jdsupra.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up